Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

Eli Lilly's treatment for early Alzheimer's was deemed too expensive for wide use by UK's cost-effectiveness body on ...

(Reuters) -British finance minister Rachel Reeves is expected to impose national insurance on employers' pension contribution ...

A first-of-its-kind study testing an mRNA vaccine for norovirus, the highly contagious winter vomiting bug, is launching in ...

For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...

Wes Streeting has suggested that no-show patients may be fined in the future because NHS lost £1 billion to nearly eight million missed NHS appointments in the last year.

The UK Government has recommended offering a COVID-19 booster vaccination in autumn, 2024, to individuals at high risk of ...

The government has been urged to prioritize funding and fast-track the implementation of the National Community Health ...

Initiatives aimed at getting homeless people healthier and off the streets are running up against new, aggressive crackdowns.

This is the second time a new Alzheimer's treatment has been rejected by the health spending watchdog in a matter of months.

Public service trade union Fórsa has warned the health service recruitment embargo is impacting on the system and could lead ...